🇺🇸 FDA
Pipeline program

A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administration of 2% and 4% lidocaine gel into the urethra

LIDEXU

Phase 1 other active

Quick answer

A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administration of 2% and 4% lidocaine gel into the urethra for bioavailability trial with healthy participants, therapeutic indication not studied is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
bioavailability trial with healthy participants, therapeutic indication not studied
Phase
Phase 1
Modality
other
Status
active

Clinical trials